DHHC21 is a STIM1 protein S-acyltransferase that modulates immune function in vivo

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Depletion of calcium from ER stores leads to the activation of calcium channels on the plasma membrane. This process is termed store-operated calcium entry (SOCE). The proteins STIM1 and STIM2 function as ER calcium sensors, and upon store depletion, they undergo a conformational change that allows them to bind to and gate Orai calcium channels on the plasma membrane. We have shown that both Orai1 and STIM1 are dynamically S-acylated after store depletion, which is required for SOCE. These results suggest the requirement of a calcium-activated protein S-acyltransferase such as DHHC21. Here, we show that DHHC21 is required for SOCE in vitro and in vivo . Using the depilated mouse model that expresses DHHC21 but can no longer be activated by calcium, we show that DHHC21 is required for STIM1 S-acylation and subsequent calcium entry. Plasma membrane-localized DHHC21 is dynamically recruited into Orai1/STIM1 puncta upon store depletion, where it physically binds to STIM1. Finally, we show that depilated mice phenocopy many aspects of autoimmune lymphoproliferative syndrome (ALPS), including defective Fas-mediated calcium release, T cell death, neutropenia, and increased serum vitamin B12 levels. These results suggest that dynamic S-acylation has underappreciated and expansive roles in second messenger signaling and immune system function. Therapeutic targeting of DHHC21 may be beneficial for ALPS and diseases associated with inappropriate activation of STIM1, such as tubular aggregate myopathy and Stormorken syndrome.

Article activity feed